Maria Tulpan
Endocrinology, Diabetes & Metabolism · New York, NYNPI 1598766560
Payments from drug & device makers
Across 264 payments — averaging $23.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$923
- Lilly USA, LLC$895
- AstraZeneca$851
- Mannkind Corporation$601
- Sanofi-aventis U.S. LLC$475
- AbbVie$468
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,06799%
- Education$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $923 |
| Lilly USA, LLC | 46 | $895 |
| AstraZeneca(2 entities) | 29 | $851 |
| Mannkind Corporation | 10 | $601 |
| Sanofi-aventis U.S. LLC | 19 | $475 |
| AbbVie | 18 | $468 |
| Radius Health, Inc. | 19 | $356 |
| Boehringer Ingelheim | 14 | $316 |
| Senseonics, Incorporated | 1 | $193 |
| Merck | 14 | $189 |
| Amgen | 12 | $189 |
| Edwards Lifesciences | 2 | $165 |
| Johnson & Johnson | 8 | $148 |
| Endo Pharmaceuticals Inc. | 4 | $74 |
| Amarin Pharma, Inc. | 3 | $63 |
| Dexcom, Inc. | 3 | $58 |
| Medtronic | 1 | $42 |
| IBSA Pharma Inc. | 2 | $35 |
| Corcept Therapeutics | 1 | $23 |
| Insulet Corporation | 1 | $22 |
| Abbott | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,150 in reported general payments places this provider in the 70th percentile of 804 endocrinology, diabetes & metabolism providers in New York.
See all endocrinology, diabetes & metabolism providers in New York →
Other endocrinology, diabetes & metabolism in New York
- Anastasios ManessisNew York$4.4M
- Adi CohenNew York$2.5M
- Carol LevyNew York$2.2M
- Mishaela RubinNew York$2M
- Henry GinsbergNew York$1M
- John BilezikianNew York$814K
- Eliza GeerNew York$760K
- Christoph BuettnerNew York$709K
- Emily SteinNew York$489K
- Jason BakerNew York$489K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.